An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites MF Attia, N Anton, J Wallyn, Z Omran, TF Vandamme Journal of Pharmacy and Pharmacology 71 (8), 1185-1198, 2019 | 785 | 2019 |
Signalling pathways in UHRF1-dependent regulation of tumor suppressor genes in cancer M Alhosin, Z Omran, MA Zamzami, AL Al-Malki, H Choudhry, M Mousli, ... Journal of Experimental & Clinical Cancer Research 35, 1-11, 2016 | 125 | 2016 |
Photochemical tools to study dynamic biological processes A Specht, F Bolze, Z Omran, JF Nicoud, M Goeldner HFSP journal 3 (4), 255-264, 2009 | 103 | 2009 |
Time-resolved WAXS reveals accelerated conformational changes in iodoretinal-substituted proteorhodopsin E Malmerberg, Z Omran, JS Hub, X Li, G Katona, S Westenhoff, ... Biophysical journal 101 (6), 1345-1353, 2011 | 76 | 2011 |
Small molecule kinase inhibitors as anti-cancer therapeutics O Chahrour, D Cairns, Z Omran Mini reviews in medicinal chemistry 12 (5), 399-411, 2012 | 70 | 2012 |
Development of doxorubicin hydrochloride loaded pH-sensitive liposomes: Investigation on the impact of chemical nature of lipids and liposome composition on pH-sensitivity AU Rehman, Z Omran, H Anton, Y Mély, S Akram, TF Vandamme, ... European Journal of Pharmaceutics and Biopharmaceutics 133, 331-338, 2018 | 59 | 2018 |
Synthesis and biological evaluation as AChE inhibitors of new indanones and thiaindanones related to donepezil Z Omran, T Cailly, E Lescot, J Sopkova-de Oliveira Santos, ... European journal of medicinal chemistry 40 (12), 1222-1245, 2005 | 44 | 2005 |
H1–nucleosome interactions and their functional implications J Bednar, A Hamiche, S Dimitrov Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1859 (3), 436-443, 2016 | 43 | 2016 |
Proton pump inhibitors for the treatment of cancer in companion animals M Walsh, S Fais, EP Spugnini, S Harguindey, T Abu Izneid, L Scacco, ... Journal of Experimental & Clinical Cancer Research 34, 1-9, 2015 | 41 | 2015 |
Physical and biological characteristics of multi drug resistance (MDR): An integral approach considering pH and drug resistance in cancer Z Omran, P Scaife, S Stewart, C Rauch Seminars in Cancer Biology 43, 42-48, 2017 | 35 | 2017 |
Thymoquinone challenges UHRF1 to commit auto-ubiquitination: A key event for apoptosis induction in cancer cells A Ibrahim, M Alhosin, C Papin, K Ouararhni, Z Omran, MA Zamzami, ... Oncotarget 9 (47), 28599, 2018 | 32 | 2018 |
Evaluation of antimicrobial activity of Triphala constituents and nanoformulation Z Omran, A Bader, A Porta, T Vandamme, N Anton, Z Alehaideb, ... Evidence-Based Complementary and Alternative Medicine 2020, 2020 | 28 | 2020 |
Acid-mediated Lipinski’s second rule: Application to drug design and targeting in cancer Z Omran, C Rauch European Biophysics Journal 43, 199-206, 2014 | 28 | 2014 |
Synthetic strigolactone analogues reveal anti-cancer activities on hepatocellular carcinoma cells MN Hasan, H Choudhry, SS Razvi, SS Moselhy, TA Kumosani, ... Bioorganic & medicinal chemistry letters 28 (6), 1077-1083, 2018 | 27 | 2018 |
Targeting microRNA/UHRF1 pathways as a novel strategy for cancer therapy H Choudhry, MA Zamzami, Z Omran, W Wu, M Mousli, C Bronner, ... Oncology letters 15 (1), 3-10, 2018 | 19 | 2018 |
CpG Islands shape the epigenome landscape C Papin, S Le Gras, A Ibrahim, H Salem, MM Karimi, I Stoll, I Ugrinova, ... Journal of molecular biology 433 (6), 166659, 2021 | 17 | 2021 |
Repurposing disulfiram as an anti-obesity drug: treating and preventing obesity in high-fat-fed rats Z Omran, R Sheikh, OA Baothman, MA Zamzami, M Alarjah Diabetes, Metabolic Syndrome and Obesity, 1473-1480, 2020 | 17 | 2020 |
Obesity: current treatment and future horizons Z Omran Mini reviews in medicinal chemistry 17 (1), 51-61, 2017 | 17 | 2017 |
Synthesis and Characterization of Cell‐Permeable Caged Phosphates that Can Be Photolyzed by Visible Light or 800 nm Two‐Photon Photolysis C Herbivo, Z Omran, J Revol, H Javot, A Specht ChemBioChem 14 (17), 2277-2283, 2013 | 17 | 2013 |
Synthesis and in vitro evaluation of novel pro-drugs for the treatment of nephropathic cystinosis Z Omran, KA Moloney, A Benylles, G Kay, RM Knott, D Cairns Bioorganic & medicinal chemistry 19 (11), 3492-3496, 2011 | 17 | 2011 |